Most vendor oversight strategies look robust on paper, but far fewer stand up to scrutiny when you examine when key decisions are actually made. This article explores the three common ways organisations build trust in their vendors, from pre-qualification audits to early in-study oversight, and challenges the assumption that these are simply operational choices. Instead, each approach reflects a different level of risk acceptance, often shaped more by timing, pressure, and internal dynamics than by deliberate design. Drawing on patterns seen across preclinical, clinical, and CSV environments, the piece questions whether audits are truly informing decisions or merely responding to them, and invites readers to reconsider how and when confidence in a vendor is really established.
Most vendor oversight approaches are not consciously designed; they are shaped by timing, pressure, and decisions that have already been made. This practical tool reframes vendor audits as a decision-making problem rather than a compliance activity, guiding readers through five focused questions to determine when confidence is needed, what kind of assurance is required, and how much risk can realistically be carried. By clarifying the trade-offs between different oversight models, it helps QA and operational teams move from reactive auditing to deliberate, risk-based decisions made before work begins. The result is a more aligned, proportionate approach to vendor oversight that strengthens confidence in data without unnecessary burden.